Shared on 30 Oct 25
Galenica's analyst price target remains unchanged at CHF 85.50. Analysts cite minimal revisions to growth and margin assumptions since the previous update.
Shared on 16 Oct 25
Fair value Increased 1.54%Expanding Diagnostics And Digital Health Will Transform Healthcare Markets
Analysts have raised their price target for Galenica from CHF 84.20 to CHF 85.50. They cite updated financial models and a slightly improved near-term outlook, despite only minor adjustments to underlying growth forecasts.
Shared on 01 May 25
Fair value Increased 6.05%Expanding Diagnostics And Digital Health Will Transform Healthcare Markets
Shared on 23 Apr 25
Home Care Expansion And Digital Initiatives Will Drive Future Success
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 17 Apr 25
Home Care Expansion And Digital Initiatives Will Drive Future Success
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 09 Apr 25
Home Care Expansion And Digital Initiatives Will Drive Future Success
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 02 Apr 25
Fair value Increased 0.94%Home Care Expansion And Digital Initiatives Will Drive Future Success
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 26 Mar 25
Home Care Expansion And Digital Initiatives Will Drive Future Success
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 19 Mar 25
Fair value Decreased 6.36%Home Care Expansion And Digital Initiatives Will Drive Future Success
AnalystConsensusTarget made no meaningful changes to valuation assumptions.